Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

Dinesh Arab, Abutaher M. Yahia, Adnan I. Qureshi

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.

Original languageEnglish (US)
Pages (from-to)61-66
Number of pages6
JournalInternational Journal of Cardiovascular Interventions
Volume5
Issue number2
DOIs
StatePublished - Jun 2 2003

Keywords

  • Abciximab
  • Angioplasty
  • Carotid stent
  • Hyperperfusion

Fingerprint Dive into the research topics of 'Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement'. Together they form a unique fingerprint.

Cite this